Design Therapeutics, Inc.DSGNNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank67
3Y CAGR+31.2%
5Y CAGR+103.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+31.2%/yr
Annual compound
5Y CAGR
+103.7%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
35.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$9.68M-24.4%
2024$12.79M+13.0%
2023$11.33M+164.4%
2022$4.29M+1337.9%
2021$298000.00+8.0%
2020$276000.00+298.6%
2019$-139000.00-